Tumor board discussions are valued by oncologists but may be associated with higher distress in patients aware of the discussion, possibly due to case complexity.
Patient awareness of tumor board discussion may heighten distress; leaves open whether oncologist-perceived benefits justify routine disclosure.
Participation in tumor boards is perceived as beneficial by oncologists and not just considered as a fulfillment of societies' recommendations or guidelines. The higher distress levels in patients who knew that their case was discussed at a tumor board may have occurred because more difficult cases are discussed at tumor boards and since the oncologists spend more time explaining the therapy process in complex cases, including the tumor board results.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: